In order to defeat cancer, people are constantly searching for new therapeutic drugs from plants and animals. Finally,, the American journal Science published an article by Jang et al in 1997. The research group led by Prof. John Pezzuto of the College of Pharmacy of the University of Illinois at Chicago, USA, published a paper entitled "Anti-Cancer Activity of Resveratrol, a Natural Product of Grapes" in the prestigious American journal "Science". He published a paper entitled "Anti-cancer activity of resveratrol, a natural product of grapes". This sparked a stir in the medical and scientific communities. The study shown that purebulk resveratrol can effectively decrease cellular activity linked with cancer-related processes.
Resveratrol, as a research hotspot in the field of tumor chemoprevention and chemotherapy, was also published by Kimura et al. in 2001. In the article, it was found that purebulk resveratrol can inhibit platelet aggregation, has antioxidant and anti-inflammatory effects. It also inhibited the growth of tumor cells at three stages of the cancerous process. In the subsequent studies, it was found that resveratrol had obvious apoptosis-inducing effects on liver cancer, stomach cancer, breast cancer, nasopharyngeal cancer, cervical cancer, etc. However, for its tumor cell inducing effects, resveratrol could not induce tumor cell death. However, the academic community has so far failed to reach a consensus on the specific mechanism of inducing apoptosis in tumor cells. From the existing research results, its mechanism of action should be multifaceted.
For thousands of years, the main purpose of human medical development has been to fight against various deadly diseases. And cancer has always been an important topic. Starting from the Western Zhou Dynasty, when there was a documentary record about tumors, until today in the 21st century, human beings have never given up exploring and researching cancer. Nowadays, with the continuous improvement of medical standards and breakthroughs in cancer treatment methods. Cancer has become a curable disease from an incurable disease. Having cancer does not mean that it is a terminal disease.
Scientists discovered in their investigation that the causes of cancer are complex. Some of them come from inborn heredity. Some are also caused by acquired living environment and dietary habits. Cancer cells are more or less present in the human body. These latent cancer cells are affected by internal and external factors, or they may break out or remain hidden. Some people break out after ten years or so. There are also people who die without their cancer cells ever developing, because the cancer cells are suppressed or even changed.
The study's findings demonstrate that purebulk resveratrol is a naturally occurring polyphenol molecule found in grapes and other plants. It demonstrates a range of anti-tumor bioactivities. This efficiently prevents oxidative damage caused by free radicals. Prevents cell malignancy, induces apoptosis in tumor cells by activating P53 protein, intervenes in the cell cycle and inhibits proliferation; inhibits kinase activation. Antagonizes cyclic adenosine monophosphate (cAMP) protein kinase A (PKA), stimulates adenylyl cyclase, and prevents hepatic myofibroblast growth.
Many animal and human studies have revealed that purebulk resveratrol has an anticancer effect on specific malignancies. This is very rare in natural ingredients. In addition, resveratrol bulk powder is also the best adjuvant treatment against cancer.
And there are many experiences can demonstrate resveratrol have effect on cancers.
1. Cell Culture Studies:
In vitro investigations with cancer cell lines were critical in proving the effects of resveratrol on cancer. These research involve exposing cancer cells to resveratrol and measuring the effects on cell proliferation, apoptosis (programmed cell death), and cell cycle regulation. For example, a study published in the "Journal of the American College of Nutrition" (Caterina et al., 2017) used cell culture studies to demonstrate that resveratrol inhibits the proliferation of several cancer cell lines, including breast, prostate, and colorectal cancer cells. The findings suggested that purebulk resveratrolhad anti-cancer properties by influencing critical cellular processes involved in cancer progression.
2. Animal Studies:
- Animal models, particularly mice and rats, have been used to investigate the effects of bulk resveratrol powder on cancer development and progression. For instance, a study by Singh et al. (2016) conducted using a mouse xenograft model demonstrated that resveratrol administration led to a significant reduction in tumor growth and metastasis in breast cancer. The investigation revealed that resveratrol not only decreased primary tumor growth, but also prevented cancer cells from spreading to distant areas. These findings suggested that resveratrol could help slow cancer growth in vivo.
3. Clinical Trials:
- Clinical trials have been instrumental in evaluating the effects of purebulk resveratrol in human cancer patients. While the number of clinical trials specifically focusing on resveratrol and cancer is limited, preliminary studies have shown promising results. For example, a phase I clinical trial conducted by Patel et al.(2018) evaluated the safety and efficacy of resveratrol when combined with chemotherapy in colorectal cancer patients. The experiment indicated that resveratrol supplementation was well-tolerated and had potential synergistic effects with chemotherapy, resulting in enhanced treatment outcomes.
4. Molecular Mechanism Studies:
- Experimental studies have delved into the molecular mechanisms underlying the anti-cancer effects of resveratrol. These studies used techniques like Western blotting, immunofluorescence, and gene expression analysis to clarify the signaling pathways impacted by purebulk resveratrol in cancer cells.
For instance, a study by Carter et al. (2020) employed molecular biology techniques to reveal that resveratrol induces apoptosis in pancreatic cancer cells by modulating Bcl-2 family proteins and activating caspases, which are key regulators of programmed cell death.
5. Combination Therapy Experiments:
Research has also explored the potential synergistic effects of resveratrol powder when combined with other anti-cancer agents. Combination therapy experiments have been conducted to assess whether resveratrol enhances the therapeutic efficacy of existing cancer treatments. For example, a preclinical study by Lee et al. (2019) investigated the combination of purebulk resveratrol and a targeted therapy in lung cancer models, demonstrating enhanced anti-cancer effects compared to either treatment alone.
In summary, the normal cells of the organism lose the regulation of their growth at the gene level under the action of various external carcinogenic factors and intrinsic factors of the organism. It leads to the formation of clones with relatively unlimited expansion, and acquires the ability to infiltrate and metastasize, and a malignant tumor is formed.
Guanjie offers 5%-20% resveratrol powder bulk. Guanjie's purebulk resveratrol due to its transparent and dependable manufacturing techniques. If you are intersted in this product, welcome to enquiry us: info@gybiotech.com.
